Skip to main content
Clinical Trials/NCT02447523
NCT02447523
Completed
Not Applicable

The Impact of Metabolic Syndrome on Patients Undergoing Elective Laparotomy

University of Ioannina0 sites105 target enrollmentSeptember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolic Syndrome
Sponsor
University of Ioannina
Enrollment
105
Primary Endpoint
Acute Kidney Injury (AKI) as defined by Kidney Disease Improving Global Outcomes (KDIGO) guidelines
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Worldwide, the rising incidence of obesity has led to the identification of an obesity related syndrome, called metabolic. This syndrome is characterized by central obesity, hypertension, insulin resistance and altered lipid levels.

Taking into consideration the rising incidence of obesity, anesthetists will more frequently encounter patients with metabolic syndrome, in their everyday practice. Moreover, the comorbidities that are related to the metabolic syndrome, increase the risk for perioperative complications. Therefore, strategies that will evaluate and modify the risk will be of great importance in the management of these patients, in order to maximize peri-anaesthetic and surgical safety.

The aim of the study is to assess the incidence of metabolic syndrome and the impact of its presence on the outcome of patients undergoing elective laparotomy.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
December 2014
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Petros Tzimas

Assistant Professor of Anaesthesiology

University of Ioannina

Eligibility Criteria

Inclusion Criteria

  • Adult patients are undergoing elective laparotomy of estimated duration of more than one hour. All operations will be performed under general anesthesia.

Exclusion Criteria

  • Endstage neoplasia
  • Procedures performed within 1 hour of admission
  • Emergency cases

Outcomes

Primary Outcomes

Acute Kidney Injury (AKI) as defined by Kidney Disease Improving Global Outcomes (KDIGO) guidelines

Time Frame: 2 Weeks

Surgical site infection (superficial or deep) as defined by European Perioperative Clinical Outcome (EPCO) definitions guidelines.

Time Frame: 2 Weeks

Postoperative pulmonary complications as defined by European Perioperative Clinical Outcome (EPCO) definitions guidelines.

Time Frame: 2 Weeks

Perioperative and postoperative adverse cardiac and cerebrovascular events as defined by European Perioperative Clinical Outcome (EPCO) definitions guidelines.

Time Frame: 2 Weeks

Similar Trials